Treatment of upper limb deep vein thrombosis with low molecular weight heparin

被引:2
|
作者
Shah, MK [1 ]
Black-Schaffer, RM [1 ]
机构
[1] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA
关键词
upper extremity; deep vein thrombosis; treatment; low molecular weight heparin;
D O I
10.1097/01.PHM.0000064740.19570.2A
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Upper limb deep vein thrombosis has been an under-recognized disease; however, physicians' awareness of it as a cause of arm pain and edema is increasing. Previously thought of as benign, upper limb deep vein thrombosis has been shown in recent studies to pose a significant risk for pulmonary embolus and death. The need for treatment is now recognized; however, effective treatments for upper limb deep vein thrombosis have not been fully defined. Anticoagulation with oral agents is known to be successful in preventing complications and recurrence. This report presents the first case of upper limb deep vein thrombosis successfully treated with only low molecular weight heparin.
引用
收藏
页码:415 / 417
页数:3
相关论文
共 50 条
  • [21] Low Molecular Weight Heparin in the Treatment of Acute Deep Vein Thrombosis and Pulmonary Embolism: A Paradigm Change in Care
    Geno J. Merli
    Journal of Thrombosis and Thrombolysis, 2000, 9 (Suppl 1) : 21 - 27
  • [22] The economic impact of treating deep vein thrombosis with low-molecular-weight heparin: Outcome of therapy and health economy aspects - Low-molecular-weight heparin versus unfractionated heparin
    Hull, RD
    Pineo, GF
    Raskob, GE
    HAEMOSTASIS, 1998, 28 : 8 - 16
  • [23] Low molecular weight heparin versus coumarin in the prevention of recurrence after deep vein thrombosis
    Hamann, H
    ZENTRALBLATT FUR CHIRURGIE, 1999, 124 (01): : 24 - 26
  • [24] Clinical trial of prevention of deep vein thrombosis on implantable infusion devices by a low molecular weight heparin.
    Pucheu, A
    Leduc, B
    SilletBach, I
    Payen, C
    Assaf, W
    Pucheu, M
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1996, 45 (02): : 59 - 63
  • [25] Low-molecular-weight heparins in the treatment of deep-vein thrombosis
    Martineau, P
    Tawil, N
    ANNALS OF PHARMACOTHERAPY, 1998, 32 (05) : 588 - +
  • [26] Out of hospital treatment with subcutaneous low molecular weight heparin in patients with acute deep-vein thrombosis: a prospective study in daily practice
    Zidane, Majida
    van Hulsteijn, Leonard H.
    Brenninkmeijer, Bernard J.
    Huisman, Menno, V
    HAEMATOLOGICA, 2006, 91 (08) : 1052 - 1058
  • [27] Treatment of deep venous thrombosis with low molecular weight heparin in pediatric cancer patients: safety and efficacy
    Tousovska, Katerina
    Zapletal, Ondrej
    Skotakova, Jarmila
    Bukac, Josef
    Sterba, Jaroslav
    BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (07) : 583 - 589
  • [28] Prevention of Deep Vein Thrombosis by Panax Notoginseng Saponins Combined with Low-Molecular-Weight Heparin in Surgical Patients
    Chun-mei Wang
    Xiang-feng Guo
    Li-min Liu
    Ying Huang
    Liang Meng
    Li-po Song
    Ying-feng Wu
    Ya-chan Ning
    Kathleen H. Reilly
    Hai-bo Wang
    Chinese Journal of Integrative Medicine, 2022, 28 : 771 - 778
  • [29] Deep vein thrombosis prevention in joint arthroplasties - Continuous enhanced circulation therapy vs low molecular weight heparin
    Gelfer, Y
    Tavor, H
    Oron, A
    Peer, A
    Halperin, N
    Robinson, D
    JOURNAL OF ARTHROPLASTY, 2006, 21 (02): : 206 - 214
  • [30] Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis
    Senzolo, Marco
    Piano, Salvatore
    Shalaby, Sarah
    Tonon, Marta
    Tonello, Silvia
    Zanetto, Alberto
    Sacerdoti, David
    Simioni, Paolo
    Bombonato, Giancarlo
    Burra, Patrizia
    Angeli, Paolo
    AMERICAN JOURNAL OF MEDICINE, 2021, 134 (10): : 1278 - +